By promoting efficient fat metabolism and reducing the formation of new fat deposits, AOD9604 can help mitigate risks associated with obesity-related conditions, such as diabetes, hypertension, and cardiovascular diseases
Shortly after, FDA added BPC-157 to its Category 2 Bulk Substance List, designating it as ineligible for compounding for human use
At the same time, appetite changes, gastrointestinal symptoms, or impaired absorption may limit oral intakemaking repletion more challenging through diet or supplements alone
Do not use if you are allergic to hydroxocobalamin, cyanocobalamin, cobalt, or any ingredients in this product (can cause severe allergic reaction)
This is where a multi-faceted approach becomes essential
The formulation contains no fillers, stabilizers, or additional additives, ensuring consistency for research applications